Table 4 Possible factors May be associated with mortality in 1-year follow-up between two groups.
Characteristics | Morality group (n = 88) | Survival group (n = 1172) | p |
---|---|---|---|
Age (years) | 82.0 (76.5–87.0) | 80.0 (74.0–85.0) | 0.017 |
Gender, n (%) | 0.574 | ||
Male | 24 (27.3%) | 353 (30.1%) | |
Female | 64 (72.7%) | 819 (69.9%) | |
BMI (kg/m2) | 22.5 (20.0–24.2) | 22.9 (20.8–25.1) | 0.042 |
Normal (BMI < 24 kg/m2) | 62 (70.5%) | 776 (66.2%) | 0.368 |
Overweight (24 ≤ BMI < 28 kg/m2) | 23 (26.1%) | 312 (26.6%) | |
Obesity (BMI ≥ 28 kg/m2) | 3 (3.4%) | 84 (7.2%) | |
Fracture type, n (%) | 0.821 | ||
Stable (A1.1–A2.1) | 46 (52.3%) | 598 (51.0%) | |
Unstable (A2.2–A3.3) | 42 (47.7%) | 574 (49.0%) | |
Time from injury to surgery (days) | 6.0 (4.0–8.0) | 6.0 (4.0–7.0) | 0.116 |
Time from injury to hospital (h) | 14.0 (6.5–22.0) | 9.0 (5.0–20.0) | 0.038 |
Operation time (min) | 90.0 (75.0–130.0) | 90.0 (75.0–120.0) | 0.606 |
≤ 60 | 13 (14.8%) | 196 (16.7%) | 0.635 |
> 60 | 75 (85.2%) | 976 (83.3%) | |
Blood loss (mls) | 200.0 (175.0–300.0) | 200.0 (150.0–300.0) | 0.748 |
ASA, n (%) | 0.224 | ||
1 | 16 (18.2%) | 211 (18.0%) | |
2 | 23 (26.1%) | 327 (27.9%) | |
3 | 27 (30.7%) | 427 (36.4%) | |
4 | 16 (18.2%) | 174 (14.8%) | |
5 | 6 (6.8%) | 33 (2.8%) | |
General anesthesia, n (%) | 0.410 | ||
Yes | 31 (35.2%) | 465 (39.7%) | |
No | 57 (64.8%) | 707 (60.3%) | |
Hospital stay (days) | 14.0 (10.5–20.0) | 13.0 (10.0–17.0) | 0.147 |
Blood transfusion volume, U | |||
Total | 4.0 (3.0–6.0) | 4.0 (2.0–6.0) | 0.224 |
Pre-operation | 0.0 (0.0–2.0) | 0.0 (0.0–2.0) | 0.190 |
Intra-operation | 2.0 (0.0–2.0) | 2.0 (0.0–2.0) | 0.964 |
Post-operation | 2.0 (0.0–2.0) | 2.0 (0.0–2.0) | 0.686 |
Pre-operation + intra-operation | 2.0 (2.0–4.0) | 2.0 (2.0–4.0) | 0.422 |
Pre-operation + post-operation | 4.0 (2.0–4.0) | 2.0 (0.0–4.0) | 0.226 |
Intra-operation + post-operation | 2.0 (2.0–4.0) | 2.0 (2.0–4.0) | 0.858 |
Number of transfusion, n (%) | |||
Total | 2.0 (1.0–3.0) | 2.0 (1.0–3.0) | 0.270 |
Pre-operation | 0.0 (0.0–1.0) | 0.0 (0.0–1.0) | 0.240 |
Intra-operation | 1.0 (0.0–1.0) | 1.0 (0.0–1.0) | 0.830 |
Post-operation | 0.0 (0.0–1.0) | 1.0 (0.0–1.0) | 0.385 |
Pre-operation + intra-operation | 1.0 (1.0–2.0) | 1.0 (1.0–2.0) | 0.278 |
Pre-operation + post-operation | 1.0 (0.5–2.0) | 1.0 (0.0–2.0) | 0.493 |
Intra-operation + post-operation | 1.0 (1.0–2.0) | 1.0 (1.0–2.0) | 0.472 |
Hemoglobin (g/L) | |||
Admission | 103.5 (91.0–116.1) | 104.9 (93.8–115.9) | 0.474 |
One day after surgery | 104.0 (90.6–113.0) | 99.0 (90.0–109.2) | 0.085 |
Minimum | 86.9 (78.4–95.1) | 87.8 (80.5–96.6) | 0.382 |
Discharge | 104.0 (94.5–112.9) | 103.2 (95.8–110.3) | 0.635 |
Vein thrombosis (Admission), n (%) | 0.200 | ||
Yes | 35 (39.8%) | 549 (46.8%) | |
No | 53 (60.2%) | 623 (53.2%) | |
Electrolyte disturbance (Admission), n (%) | 0.226 | ||
Yes | 2 (2.3%) | 67 (5.7%) | |
No | 86 (97.7%) | 1105 (94.3%) | |
Comorbidities, n (%) | |||
Anemia | 0.620 | ||
Yes | 3 (3.4%) | 64 (5.5%) | |
No | 85 (96.6%) | 1108 (94.5%) | |
Dementia | 0.974 | ||
Yes | 6 (6.8%) | 81 (6.9%) | |
No | 82 (93.2%) | 1091 (93.1%) | |
Pneumonia | 0.023 | ||
Yes | 13 (14.8%) | 92 (7.8%) | |
No | 75 (85.2%) | 1080 (92.2%) | |
Arteriosclerosis | 0.915 | ||
Yes | 17 (19.3%) | 221 (18.9%) | |
No | 71 (80.7%) | 951 (81.1%) | |
Cerebrovascular disease | 0.145 | ||
Yes | 10 (11.4%) | 204 (17.4%) | |
No | 78 (88.6%) | 968 (82.6%) | |
Hypoproteinemia | 0.198 | ||
Yes | 4 (4.5%) | 99 (8.4%) | |
No | 84 (95.5%) | 1073 (91.6%) | |
Arrhythmology | 0.957 | ||
Yes | 10 (11.4%) | 131 (11.2%) | |
No | 78 (88.6%) | 1041 (88.8%) | |
Heart failure | 0.201 | ||
Yes | 5 (5.7%) | 36 (3.1%) | |
No | 83 (94.3%) | 1136 (96.9%) | |
Myocardial infarction | 0.621 | ||
Yes | 0 (0.0%) | 16 (1.4%) | |
No | 88 (100.0%) | 1156 (98.6%) | |
Diabetes | 0.186 | ||
Yes | 22 (25.0%) | 225 (19.2%) | |
No | 66 (75.0%) | 947 (80.8%) | |
Cerebral hemorrhage | 0.612 | ||
Yes | 1 (1.1%) | 12 (1.0%) | |
No | 87 (98.9%) | 1160 (99.0%) | |
Cerebral infarction | 0.965 | ||
Yes | 18 (20.5%) | 242 (20.6%) | |
No | 70 (79.5%) | 930 (79.4%) | |
Coronary heart disease | 0.388 | ||
Yes | 15 (17.0%) | 245 (20.9%) | |
No | 73 (83.0%) | 927 (79.1%) | |
Hypertension | 0.212 | ||
Yes | 46 (52.3%) | 532 (45.4%) | |
No | 42 (47.7%) | 640 (54.6%) | |
Complications, n (%) | |||
Heart failure | 0.003 | ||
Yes | 15 (17.0%) | 92 (7.8%) | |
No | 73 (83.0%) | 1080 (92.2%) | |
Respiratory failure | 0.053 | ||
Yes | 5 (5.7%) | 25 (2.1%) | |
No | 83 (94.3%) | 1147 (97.9%) | |
Cerebral infarction | 1.000 | ||
Yes | 3 (3.4%) | 43 (3.7%) | |
No | 85 (96.6%) | 1129 (96.3%) | |
Stress ulcer | 0.719 | ||
Yes | 1 (1.1%) | 30 (2.6%) | |
No | 87 (98.9%) | 1142 (97.4%) | |
Arrhythmology | 0.456 | ||
Yes | 18 (20.5%) | 203 (17.3%) | |
No | 70 (79.5%) | 969 (82.7%) | |
Pneumonia | 0.138 | ||
Yes | 14 (15.9%) | 126 (10.8%) | |
No | 74 (84.1%) | 1046 (89.2%) | |
Delirium | 0.244 | ||
Yes | 9 (10.2%) | 81 (6.9%) | |
No | 79 (89.8%) | 1091 (93.1%) | |
Anemia | 0.061 | ||
Yes | 10 (11.4%) | 73 (6.2%) | |
No | 78 (88.6%) | 1099 (93.8%) | |
Vein thrombosis | 0.416 | ||
Yes | 34 (38.6%) | 505 (43.1%) | |
No | 54 (61.4%) | 667 (56.9%) | |
Electrolyte disturbance | 0.935 | ||
Yes | 40 (45.5%) | 538 (45.9%) | |
No | 48 (54.5%) | 634 (54.1%) | |
Hypoproteinemia | 0.688 | ||
Yes | 27 (30.7%) | 336 (28.7%) | |
No | 61 (69.3%) | 836 (71.3%) | |
Hyperglycemia | 0.135 | ||
Yes | 29 (32.9%) | 301 (25.7%) | |
No | 59 (67.1%) | 871 (74.3%) |